Jacob Steven Leach, SVP, Research & Development at DEXCOM INC (DXCM), sold 9,228 shares at $143.76 ($1.3M) on 2018-09-10, disclosed to the SEC on 2018-09-12.
Open-market sale of $1.3M DXCM by SVP, Research & Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $143.76 | 1,936 | $278K | 21.0% |
| 2 | $143.76 | 1,936 | $278K | 21.0% |
| 3 | $143.76 | 2,678 | $385K | 29.0% |
| 4 | $143.76 | 2,678 | $385K | 29.0% |
| Total | $143.76 avg | 9,228 | $1.3M | 100% |
| Filing → |
| DXCM | SELL | 2025-03-14 | $2.0M | — | Filing → |
| DXCM | SELL | 2025-01-30 | $458K | — | Filing → |
| DXCM | SELL | 2024-12-17 | $114K | — | Filing → |